 Cyclacel Pharmaceuticals, Inc. Nasdaq:CYCC, Nasdaq:CYCCP Cyclacel or the Company, a biopharmaceutical company developing innovative medicines based on cancer cell biology, announces that the Company will present at Biotech ShowcaseTM 2020, at 9:30 a.m. PT on January 13, in the Yosemite A Ballroom level at the Hilton San Francisco Union Square. Spiro Rombotis, President Chief Executive Officer, will provide an overview of the Company and progress in key programs. A live webcast of the presentation will be available through the Companys website: 